Print（PDF/584KB） Sep. 02, 2022 Corporate

Sumitomo Pharma Announces Personnel Changes

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following personnel changes:

Changes in Personnel (effective October 1, 2022)

Drug Research (Division)

Position as of October 1, 2022	Current position	Name
Senior Project Director, Early-phase Drug Research	Senior Director, Platform Technology Research Unit	Hidetaka Nagata
Senior Project Director, Late-phase Drug Research	Director, Pharmacology Group I, Pharmacology Research Unit	Taro Kato
Senior Director, Platform Technology Research Unit	Senior Project Director, Early-phase Drug Research	Masakazu Hashimoto

Drug Development (Division)

Position as of October 1, 2022	Current position	Name
Senior Director, Development Planning & Management Senior Director, Oncology Clinical Development Unit	Senior Director, Development Planning & Management	Katsunori Maruta